NAM logo
  • site map
  • contact
  • advanced search
  • Home
  • News
  • Treatment & Care
  • HIV Worldwide
  • Living with HIV
  • Preventing HIV
  • Organisations
  • HIV Basics
  • About Us
 
Treatment & Care
  • español
  • français
  • português
  • pусский
Ways of attacking HIV
  • Types of HIV drug
    • Summary: Ways of attacking HIV
    • Viruses
    • HIVs life-cycle
    • Multiple targets - combination therapy
    • Reverse transcriptase inhibitors
    • Protease inhibitors
    • Preventing viral attachment or fusion
    • Targeting other HIV proteins
    • Inhibiting cellular factors required for HIV replication
    • Other anti-HIV strategies
    • Killing or removing HIV-infected cells
    • Gene therapy
    • Anti-oxidants
    • Vitamins and minerals
  • Treatment strategies
    • Restoring the immune system
      • Effectiveness of HIV therapy
        support our work today
        YOU ARE HERE
        • > Home
          • > Treatment & Care
            • > Treatment & Care
              • > Ways of attacking HIV

        Types of HIV drug

        printer-friendly versionsend to a friendglossarycomment

        Information on the different classes of anti-HIV drug, describing how they disrupt the virus's life cycle. This section also includes information on experimental approaches to HIV therapy.

        • Summary: Ways of attacking HIV
        • Viruses
        • HIVs life-cycle
        • Multiple targets - combination therapy
        • Reverse transcriptase inhibitors
        • Protease inhibitors
        • Preventing viral attachment or fusion
        • Targeting other HIV proteins
        • Inhibiting cellular factors required for HIV replication
        • Other anti-HIV strategies
        • Killing or removing HIV-infected cells
        • Gene therapy
        • Anti-oxidants
        • Vitamins and minerals

        latest aidsmap news

        • Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis
        • Wide variation found in anal HPV viral loads in HIV-positive men
        • Offering rapid point-of-care tests would increase uptake of HIV testing
        • Low rate of spontaneous hepatitis C clearance in patients with HIV; early HIV treatment recommended for those with chronic hepatitis C infection
        • Cluster of multi-drug resistant HIV transmissions in Seattle
        • Hypersensitivity testing for abacavir slightly more cost-effective than tenofovir use, if both drugs equally potent
        • HIV no longer bar to granting of US visa for short visits
        • Kidney disease risk increased for patients with HIV and hepatitis C
        • Nearly one in three UK HIV patients has considered suicide in the previous week
        • A new day for health in South Africa: Manto is replaced as health minister by TAC supporter
         
        • Contact NAM
        • Get Email Updates
        • Disclaimer
        • Copyright
        • Developed By NAM